Simcyp Limited Adds Blood-Brain Barrier Models to Its Population-Based Simulator and Expands Its Pharmacodynamic Capabilities

SHEFFIELD, England--(BUSINESS WIRE)--Simcyp Limited is pleased to announce significant additions to its flagship simulator in line with priorities established by the Simcyp Consortium of global pharmaceutical companies.